ExodusPoint Capital Management, LP - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$51
-99.8%
18,184
+65.1%
0.00%
Q2 2022$27,000
-97.0%
11,016
-94.9%
0.00%
-100.0%
Q1 2022$887,000
+639.2%
215,328
+1544.6%
0.01%
+1000.0%
Q2 2021$120,000
-20.0%
13,093
-17.6%
0.00%
-50.0%
Q1 2021$150,000
+28.2%
15,893
-46.3%
0.00%
+100.0%
Q4 2020$117,00029,6110.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders